BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11099220)

  • 1. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties.
    Sasse F; Steinmetz H; Heil J; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 2000 Sep; 53(9):879-85. PubMed ID: 11099220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis.
    Ullrich A; Chai Y; Pistorius D; Elnakady YA; Herrmann JE; Weissman KJ; Kazmaier U; Müller R
    Angew Chem Int Ed Engl; 2009; 48(24):4422-5. PubMed ID: 19431172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubulysins are Essential for the Preying of Ciliates by Myxobacteria.
    Yu U; Kim J; Park S; Cho K
    J Microbiol; 2023 Jun; 61(6):627-632. PubMed ID: 37314675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties.
    Sasse F; Steinmetz H; Schupp T; Petersen F; Memmert K; Hofmann H; Heusser C; Brinkmann V; von Matt P; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 2002 Jun; 55(6):543-51. PubMed ID: 12195959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004.
    Chai Y; Pistorius D; Ullrich A; Weissman KJ; Kazmaier U; Müller R
    Chem Biol; 2010 Mar; 17(3):296-309. PubMed ID: 20338521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gephyronic acid, a novel inhibitor of eukaryotic protein synthesis from Archangium gephyra (myxobacteria). Production, isolation, physico-chemical and biological properties, and mechanism of action.
    Sasse F; Steinmetz H; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1995 Jan; 48(1):21-5. PubMed ID: 7868385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Archazolids, new cytotoxic macrolactones from Archangium gephyra (Myxobacteria). Production, isolation, physico-chemical and biological properties.
    Sasse F; Steinmetz H; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 2003 Jun; 56(6):520-5. PubMed ID: 12931860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apicularens A and B, new cytostatic macrolides from Chondromyces species (myxobacteria): production, physico-chemical and biological properties.
    Kunze B; Jansen R; Sasse F; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1998 Dec; 51(12):1075-80. PubMed ID: 10048565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New peptaibols from Mycogone cervina.
    Wilhelm C; Anke H; Flores Y; Sterner O
    J Nat Prod; 2004 Mar; 67(3):466-8. PubMed ID: 15043434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurafuron A and B, new bioactive polyketides from Stigmatella aurantiaca and Archangium gephyra (Myxobacteria). Fermentation, isolation, physico-chemical properties, structure and biological activity.
    Kunze B; Reichenbach H; Müller R; Höfle G
    J Antibiot (Tokyo); 2005 Apr; 58(4):244-51. PubMed ID: 15981410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria.
    Khalil MW; Sasse F; Lünsdorf H; Elnakady YA; Reichenbach H
    Chembiochem; 2006 Apr; 7(4):678-83. PubMed ID: 16491500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyrmenins, new beta-methoxyacrylate inhibitors of the electron transport. Production, isolation, physico-chemical and biological properties.
    Sasse F; Leibold T; Kunze B; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 2003 Oct; 56(10):827-31. PubMed ID: 14700275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales).
    Kunze B; Kohl W; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1649-54. PubMed ID: 3937837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Archazolid A-15-O-β-D-glucopyranoside and iso-archazolid B: potent V-ATPase inhibitory polyketides from the myxobacteria Cystobacter violaceus and Archangium gephyra.
    Horstmann N; Essig S; Bockelmann S; Wieczorek H; Huss M; Sasse F; Menche D
    J Nat Prod; 2011 May; 74(5):1100-5. PubMed ID: 21513292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and analysis of the core biosynthetic machinery of tubulysin, a potent cytotoxin with potential anticancer activity.
    Sandmann A; Sasse F; Müller R
    Chem Biol; 2004 Aug; 11(8):1071-9. PubMed ID: 15324808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
    Herrmann J; Elnakady YA; Wiedmann RM; Ullrich A; Rohde M; Kazmaier U; Vollmar AM; Müller R
    PLoS One; 2012; 7(5):e37416. PubMed ID: 22616003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties.
    Kunze B; Jansen R; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1994 Aug; 47(8):881-6. PubMed ID: 7928674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and identification of Myxobacteria strain STXZ54 with antitumor activities].
    Tang S; Xiao R; Wen Y; Qin H; Liu W; Ding X; Xia L
    Wei Sheng Wu Xue Bao; 2014 May; 54(5):532-42. PubMed ID: 25199252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxochelin A, a new iron-chelating compound from Angiococcus disciformis (Myxobacterales). Production, isolation, physico-chemical and biological properties.
    Kunze B; Bedorf N; Kohl W; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1989 Jan; 42(1):14-7. PubMed ID: 2493439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melithiazols, new beta-methoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties.
    Sasse F; Böhlendorf B; Herrmann M; Kunze B; Forche E; Steinmetz H; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1999 Aug; 52(8):721-9. PubMed ID: 10580385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.